Abstract
Purpose: To provide expert consensus and evidence-based current guidelines on treatment technique, postoperative care, expected outcomes and retreatment for MicroPulse Transscleral Laser Treatment (TLT).Methods: A comprehensive search of PubMed led to the identification and analysis of 61 studies on MicroPulse TLT. To provide guidance in areas where there was not enough available literature, a three-round Delphi method was conducted involving 10 international experts in MicroPulse TLT.Results: The response rate was 70% in the first round, 70% in the second round, and 80% in the third round of the Delphi method. Once all responses were aggregated, a live meeting was held with 90% attendance, and consensus was achieved on each of the findings detailed in this manuscript.Conclusion: Used within appropriate treatment parameters, with proper technique and patient selection, MicroPulse TLT is a safe and effective treatment for many types and severities of glaucoma. MicroPulse TLT represents a useful addition to the glaucoma armamentarium.
Original language | English |
---|---|
Pages (from-to) | 71-83 |
Number of pages | 13 |
Journal | Clinical Ophthalmology |
Volume | 17 |
DOIs | |
Publication status | Published - 2023 |
Keywords
- glaucoma
- MicroPulse
- transscleral laser treatment
- REFRACTORY GLAUCOMA
- DIODE CYCLOPHOTOCOAGULATION
- CLINICAL-OUTCOMES
- SAFETY
- CYCLOPHOTOTHERAPY
- EFFICACY